Does the ketogenic ratio matter when using ketogenic diet therapy in pediatric epilepsy?
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analytic data
PubMed 36471628 · doi:10.1111/epi.17476
What was done
Narrative review examining the role of ketosis and dietary fat-to-(carbohydrate + protein) ratios (such as classic 4:1 ratios versus less-restrictive protocols like the modified Atkins diet and low glycemic index treatment) in managing medically refractory pediatric epilepsy.
What was found
The abstract reports no numerical outcomes, comparative efficacy metrics, or statistical results.
Why it matters
Addresses whether rigid, highly restrictive classic ketogenic ratios are required for seizure reduction or if more tolerable dietary variations can provide sufficient clinical control in children with drug-resistant epilepsy.
Limits
Narrative review design with no systematic search criteria, meta-analysis, or risk-of-bias evaluation. No primary human data, sample sizes, or quantitative outcome measures are reported in the abstract.
Cited by
- supports A classical 4:1 ketogenic diet consists of 90% fat and one part protein and carbohydrates combined.
- supports Low glycemic index therapy produces an anti-seizure therapeutic effect despite producing little to no elevation in blood ketones.